BMC’s Center of Excellence in Sickle Cell Disease serves more than 600 patients, from newborns to adults, annually. The center’s multidisciplinary team includes sickle cell disease specialists, as well as primary care, nurses, social workers, and departments across the hospital to ensure that patients get consistent and coordinated care. We are committed to providing patients with highly personalized care across childhood, teenage years, and adulthood so they can live as normal a life as possible.
Leading Expertise
Largest sickle cell disease center
in New England, serving over 600 adult and pediatric patients per year
Access to gene therapies
as the only hospital in New England that offers both FDA-approved gene therapies for sickle cell disease, Casgevy and Lyfegenia
Unique transitional care programs
to help patients navigate the transition of care from pediatrics to adulthood
Location and Contact
Adult Clinic
3rd Floor
Moakley Building 617.638.6428
Monday – Friday 8 a.m. to 4 p.m.
Pediatric Clinic
7th Floor
Crosstown Center 617.414.4841
Monday, Wednesday, Friday 8 a.m. to 5:30 p.m.; Tuesday, Thursday 8 a.m. to 8 p.m.
Transitional Care Program
3rd Floor
Moakley Building 617.638.6428
First Thursday of every month
Explore the Department
Related Departments and Clinics
Sickle Cell Disease - Adult Clinic
Sickle Cell Disease - Pediatric Clinic
Sickle Cell Disease - Transitional Care
"At BMC, I am able to ask questions and learn more," Ingrid says. "Advocating for yourself and your care is so important, especially for SCD." Ingrid OrtizHear more from Ingrid
Information You May Need
Education and Training
Sickle Cell Disease Advanced Fellowship
In 2022, BMC launched a one-year non-ACGME accredited fellowship in sickle cell disease to increase knowledge in the care of adults with sickle cell disease. This program, one of only two adult SCD fellowships in the US, was designed to increase the number of physicians who can care for adults living with SCD in the future.
Hematology Research Track
Fellows who are interested in hematology research can join the four-year hematology research track. While the clinical training is equivalent to the hematology/oncology fellowship, this track involves two years dedicated to basic, translational, or clinical research related to hematology.
Sickle Cell Disease Research Overview
BMC researchers are finding innovative new ways to treat and cure blood disorders. As our patient, you'll have access to a wide range of clinical trials from both BMC researchers and researchers at other institutions.